Ep. 138: Cell-Based Therapies in Late-Stage Clinical Trial
Guest: Dr. Robert Mays is the Co-founder and Vice President of Regenerative Medicine and Head of Neuroscience Programs at Athersys Inc.\xa0He focuses on Athersys\u2019s proprietary stem cell product, MultiStem\xae, and its applications in Regenerative Medicine\u2026